Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Coherus
Biotech
Coherus shrinks headcount 30% to narrow focus of cancer combo
Coherus Oncology is once again laying off 30% of its workforce as the biopharma narrows the focus of its CCR8-targeting antibody on esophageal cancer.
James Waldron
Nov 10, 2026 3:52am
Galapagos CEO eyes exit as spinout names leader—Chutes & Ladders
Apr 25, 2025 8:30am
Coherus to lose 30% of staff as part of Udenyca sale to Accord
Mar 11, 2025 7:30am
Coherus axes TIGIT program 2 years after making $35M bet
Jan 10, 2024 7:50am
Surface warns bankruptcy possible if shareholders reject merger
Aug 2, 2023 10:00am
Coherus scratches the Surface with $65M buy
Jun 16, 2023 10:45am